Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024 as against Rs 25.86 crore during the previous quarter ended September 2023. Sales rose 12.13% to Rs 172.21 crore in the quarter ended September 2024 as against Rs 153.58 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales172.21153.58 12 OPM %26.6724.28 - PBDT47.7039.02 22 PBT42.3934.79 22 NP4.2025.86 -84 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live News

Net profit of RPG Life Sciences rose 21.09% to Rs 26.76 crore in the quarter ended June 2024 as against Rs 22.10 crore during the previous quarter ended June 2023. Sales rose 11.94% to Rs 165.42 crore in the quarter ended June 2024 as against Rs 147.78 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales165.42147.78 12 OPM %23.6221.82 - PBDT41.2933.98 22 PBT36.0029.77 21 NP26.7622.10 21 Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 19 July 2024.Powered by Capital Market - Live News

RPG Life Sciences announced that the Annual General Meeting (AGM) of the company will be held on 16 July 2024.Powered by Capital Market - Live News